🔎 Trials Near Me

Gara Jalqabaatti › Lymphoma B-Cell › Minnesota › Rochester

Qorannoo klinikaalii Lymphoma B-Cell Rochester, MN keessatti

Qorannoo 10 Lymphoma B-Cell f Rochester fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)

Namoota walitti qabaa jiraSadarkaa 3
  • Mayo Clinic Rochester, Rochester
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT06742996

A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )

Namoota walitti qabaa jiraSadarkaa 1
  • Mayo Clinic - Rochester, Rochester
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07101328

Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL

Namoota walitti qabaa jiraSadarkaa 2
  • Research Site, Rochester
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 11-Ful-2026 · NCT06526793

A Study to Investigate Safety and Effectiveness of Tacabrutideg (BGB-16673) in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignancies

Namoota walitti qabaa jiraSadarkaa 1/2
  • Mayo Clinic Rochester, Rochester
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 11-Ful-2026 · NCT06634589

A Phase I/II Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma

Namoota walitti qabaa jiraSadarkaa 1/2
  • Research Site, Rochester
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Hag-2026 · NCT07123454

A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy

Namoota walitti qabaa jiraSadarkaa 3
  • Mayo Clinic Rochester, Rochester
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 04-Hag-2026 · NCT07188558

DALY II USA/ MB-CART2019.1 for DLBCL

Namoota walitti qabaa jiraSadarkaa 2
  • Mayo Clinic, Rochester
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 13-Ado-2026 · NCT04792489

A Vaccine (VSV-hIFNβ-NIS) With or Without Cyclophosphamide and Combinations of Ipilimumab, Nivolumab, and Cemiplimab in Treating Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia or Lymphoma

Namoota walitti qabaa jiraSadarkaa 1
  • Mayo Clinic in Rochester, Rochester
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 10-Wax-2026 · NCT03017820

CD19-Directed CAR-T Cell Therapy for the Treatment of Relapsed/Refractory B Cell Malignancies

Namoota walitti qabaa jiraSadarkaa 1
  • Mayo Clinic in Rochester, Rochester
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 09-Wax-2026 · NCT04892277

Family Study of Lymphoproliferative Disorders

Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
  • Mayo Clinic, Rochester
Umuriin 18 hanga 100 · Saalaa hunda · Haaromfame 14-Onk-2025 · NCT00626496

Qorannoo Lymphoma B-Cell magaalota biroo keessatti

Qorannoo biroo Rochester keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 05-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.